(Q37525797)

20 August 2017

1 reference

title

A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy (English)

1 reference

immune reconstitution inflammatory syndrome

20 August 2017

main subject

anti-retroviral agent

0 references

inflammation

0 references

1 reference

S Mori

1

1 reference

20 August 2017

P Levin

series ordinal

2

1 reference

20 August 2017

publication date

1 July 2009

1 reference

International Journal of STD & AIDS

20 August 2017

published in

1 reference

20 August 2017

volume

20

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

447-452

1 reference

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Autoimmunity during lymphopenia: a two-hit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

HIV induces thymus depletion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

The impact of highly active antiretroviral therapy on HIV-specific immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Immune restoration and CD4+ T-cell function with antiretroviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Restoration of the immune system with anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Early reduction of immune activation in lymphoid tissue following highly active HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

IL-7: maintaining T-cell memory and achieving homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses indu

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

Foxp3+ regulatory T cells in antiretroviral-naive HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2009.008521

21 January 2018

Identifiers

DOI

10.1258/IJSA.2009.008521

1 reference

release_vykrzltvp5hdloitfdir3l5v4e

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vykrzltvp5hdloitfdir3l5v4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference